Research graph
References from Factors Associated With Perceived Cognitive Dysfunction in Patients With Primary Brain Tumors: The Utility of the Neuro‐ QoL Cognition Function Scale. Local targets link to admitted publications; unresolved targets remain external evidence.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016‐2020
10.1093/neuonc/noad149 · 2023 · External reference
Epidemiology and Diagnosis of Brain Tumors
10.1212/01.con.0000464171.50638.fa · 2015 · External reference
Presenting Symptoms of Glioma in Adults
10.1111/ane.12285 · 2015 · External reference
Cognitive Effects of Tumour and Surgical Treatment in Glioma Patients
10.1007/s11060-010-0417-0 · 2011 · External reference
Relationships Between Neurocognitive Functioning, Mood, and Quality of Life in Patients With Temporal Lobe Glioma
10.1002/pon.4046 · 2017 · External reference
Effect of Neurological Dysfunction on Health‐Related Quality of Life in Patients With High‐Grade Glioma
10.1023/a:1005790632126 · 1997 · External reference
Cognitive Outcomes After Multimodal Treatment in Adult Glioma Patients: A Meta‐Analysis
10.1093/neuonc/noad045 · 2023 · External reference
Investigation of Cognitive Impairments in People With Brain Tumors
10.1007/s11060-012-0815-6 · 2012 · External reference
Pre‐ and Postoperative Neurocognitive Deficits in Brain Tumor Patients Assessed by a Computer Based Screening Test
10.1016/j.jocn.2016.10.030 · 2017 · External reference
Glioma Patient‐Reported Outcome Assessment in Clinical Care and Research: A Response Assessment in Neuro‐Oncology Collaborative Report
10.1016/s1470-2045(19)30796-x · 2020 · External reference
Developing a Valid Patient‐Reported Outcome Measure
10.1038/clpt.2011.195 · 2011 · External reference
Neuro‐QOL: Quality of Life Item Banks for Adults With Neurological Disorders: Item Development and Calibrations Based Upon Clinical and General Population Testing
10.1007/s11136-011-9958-8 · 2012 · External reference
Neuro‐QOL: Brief Measures of Health‐Related Quality of Life for Clinical Research in Neurology
10.1212/wnl.0b013e318258f744 · 2012 · External reference
Unresolved reference
External reference
Validating Neuro‐QoL Short Forms and Targeted Scales With People Who Have Multiple Sclerosis
10.1177/1352458515599450 · 2016 · External reference
Patient‐Reported Outcomes in Multiple Sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro‐QoL) Short Forms
10.1177/2055217319885986 · 2019 · External reference
Validity of the Neurology Quality‐of‐Life (Neuro‐QoL) Measurement System in Adult Epilepsy
10.1016/j.yebeh.2013.11.008 · 2014 · External reference
HDQLIFE and Neuro‐QoL Physical Function Measures: Responsiveness in Persons With Huntington's Disease
10.1002/mds.27908 · 2020 · External reference
Psychometric Properties and Responsiveness of Neuro‐QoL Cognitive Function in Persons With Huntington Disease (HD)
10.1007/s11136-019-02391-7 · 2020 · External reference
Evaluating Individual Change With the Quality of Life in Neurological Disorders (Neuro‐QoL) Short Forms
10.1016/j.apmr.2015.12.010 · 2016 · External reference
Neurocognitive Deficits Following Primary Brain Tumor Treatment: Systematic Review of a Decade of Comparative Studies
10.1007/s11060-013-1215-2 · 2013 · External reference
Health Related Quality of Life in Adult Low and High‐Grade Glioma Patients Using the National Institutes of Health Patient Reported Outcomes Measurement Information System (PROMIS) and Neuro‐QOL Assessments
10.3389/fneur.2019.00212 · 2019 · External reference
Living With a Central Nervous System (CNS) Tumor: Findings on Long‐Term Survivorship From the NIH Natural History Study
10.1093/nop/npab022 · 2021 · External reference
Cancer Neuroscience: State of the Field, Emerging Directions
10.1016/j.cell.2023.02.002 · 2023 · External reference
Chemotherapy‐Related Cognitive Impairment in Older Patients With Cancer
10.1016/j.jgo.2016.04.008 · 2016 · External reference
Factors of Subjective Versus Objective Cognitive Functioning in Patients With Stable Grades II and III Glioma
10.1093/nop/npu035 · 2015 · External reference
Neurocognition in Adults With Intracranial Tumors: Does Location Really Matter?
10.1007/s11060-022-04181-7 · 2022 · External reference
Chemobrain—Cognitive Disorders After Chemotherapy
2022 · External reference
Perioperative Considerations in Patients With Chemotherapy‐Induced Cognitive Impairment: A Narrative Review
10.1016/j.bja.2022.08.037 · 2022 · External reference
Chemotherapy‐Related Cognitive Dysfunction
10.1007/s11910-012-0264-9 · 2012 · External reference
Tumour and Surgery Effects on Cognitive Functioning in High‐Grade Glioma Patients
10.1007/s00701-014-2115-8 · 2014 · External reference
Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma
10.1227/neu.0000000000000987 · 2015 · External reference
Neurocognitive Function Before and After Surgery for Insular Gliomas
10.3171/2011.8.jns11488 · 2011 · External reference
APOE Polymorphisms and Cognitive Functions in Patients With Brain Tumors
10.1212/wnl.0000000000000617 · 2014 · External reference
Neurocognition in Patients With Brain Metastases Treated With Radiosurgery or Radiosurgery Plus Whole‐Brain Irradiation: A Randomised Controlled Trial
10.1016/s1470-2045(09)70263-3 · 2009 · External reference
Prediction Models for Radiation‐Induced Neurocognitive Decline in Adult Patients With Primary or Secondary Brain Tumors: A Systematic Review
10.3389/fpsyg.2022.853472 · 2022 · External reference
Long‐Term Cognitive Dysfunction After Radiation Therapy for Primary Brain Tumors
10.1080/0284186x.2018.1557786 · 2019 · External reference
Sustained Preservation of Cognition and Prevention of Patient‐Reported Symptoms With Hippocampal Avoidance During Whole‐Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001
10.1016/j.ijrobp.2023.04.030 · 2023 · External reference
Trajectories of Symptom Clusters, Performance Status, and Quality of Life During Concurrent Chemoradiotherapy in Patients With High‐Grade Brain Cancers
10.1097/ncc.0000000000000435 · 2018 · External reference
Peripheral Inflammation and Depressed Mood Independently Predict Neurocognitive Worsening Over 12 Years
10.1016/j.bbih.2022.100437 · 2022 · External reference
Association Between Psychological Distress, Subjective Cognitive Complaints and Objective Neuropsychological Functioning in Brain Tumor Patients
10.1016/j.clineuro.2017.10.007 · 2017 · External reference
Subjective Cognitive Functioning and Associations With Psychological Distress in Adult Brain Tumour Survivors
10.1007/s11764-019-00784-8 · 2019 · External reference
Influences on Cognitive Outcomes in Adult Patients With Gliomas: A Systematic Review
10.3389/fonc.2022.943600 · 2022 · External reference
Unresolved reference
External reference
Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI‐BT)
10.1007/s11060-006-9135-z · 2006 · External reference
Item Banks for Measuring Emotional Distress From the Patient‐Reported Outcomes Measurement Information System (PROMIS): Depression, Anxiety, and Anger
10.1177/1073191111411667 · 2011 · External reference
Minimally Important Differences Were Estimated for Six Patient‐Reported Outcomes Measurement Information System‐Cancer Scales in Advanced‐Stage Cancer Patients
10.1016/j.jclinepi.2010.11.018 · 2011 · External reference
Unresolved reference
2020 · External reference
The Symptom Burden of Primary Brain Tumors: Evidence for a Core Set of Tumor‐ and Treatment‐Related Symptoms
10.1093/neuonc/nov166 · 2016 · External reference
Long‐Term Neurocognitive, Psychological, and Return to Work Outcomes in Meningioma Patients
10.1007/s00520-022-06838-5 · 2022 · External reference
Glioblastoma Remodelling of Human Neural Circuits Decreases Survival
10.1038/s41586-023-06036-1 · 2023 · External reference
Corticosteroids in Brain Cancer Patients: Benefits and Pitfalls
10.1586/ecp.11.1 · 2011 · External reference
Corticosteroids and Cognition: A Meta‐Analysis
10.1007/s11065-019-09405-8 · 2019 · External reference
Long‐Term Patient‐Reported Neurocognitive Outcomes in Adult Survivors of Hematopoietic Cell Transplant
10.1182/bloodadvances.2021006672 · 2022 · External reference
Normal Cognitive Aging
10.1016/j.cger.2013.07.002 · 2013 · External reference
Cognitive Side Effects of Antiepileptic Drugs
10.1017/s0317167100040762 · 1994 · External reference
Assessment of Neurocognitive Function in Association With WHO Grades in Gliomas
10.1016/j.clineuro.2021.106824 · 2021 · External reference
Neurocognitive Functioning in Patients With Glioma of the Left and Right Temporal Lobes
10.1007/s11060-016-2114-0 · 2016 · External reference
Mental Impairment in Unilateral Frontal Tumours: Role of the Laterality of the Lesion
10.3109/00207458709043334 · 1987 · External reference
Primary Cognitive Factors Impaired After Glioma Surgery and Associated Brain Regions
2020 · External reference
Education and Cognitive Functioning Across the Life Span
10.1177/1529100620920576 · 2020 · External reference
Brain Metastases: Focal Treatment (Surgery and Radiation Therapy) and Cognitive Consequences
2017 · External reference
Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients
10.1093/neuros/nyaa552 · 2021 · External reference
Isocitrate Dehydrogenase, Patient‐Reported Outcomes, and Cognitive Functioning of Glioma Patients: A Systematic Review
10.1007/s11912-020-00978-9 · 2020 · External reference
The Effect of IDH1 Mutation on the Structural Connectome in Malignant Astrocytoma
10.1007/s11060-016-2328-1 · 2017 · External reference
Neurocognitive Function Varies by IDH1 Genetic Mutation Status in Patients With Malignant Glioma Prior to Surgical Resection
10.1093/neuonc/now165 · 2016 · External reference
Understanding Cognitive Functioning in Glioma Patients: The Relevance of IDH‐Mutation Status and Functional Connectivity
10.1002/brb3.1204 · 2019 · External reference
Pre‐Operative Neurocognitive Function Was More Susceptible to Decline in Isocitrate Dehydrogenase Wild‐Type Subgroups of Lower‐Grade Glioma Patients
10.3389/fneur.2020.591615 · 2020 · External reference
The Montreal Cognitive Assessment (MoCA) in Neuro‐Oncology: A Pilot Study of Feasibility and Utility in Telehealth and In‐Person Clinical Assessments
10.1093/nop/npac038 · 2022 · External reference
